Reuters - A kidney cancer drug became the first
medicine to extend the life of patients with advanced liver
cancer in a large study, adding about three months to survival
compared with a placebo, according to a data released on
Monday.
Source: http://rss.news.yahoo.com
No comments:
Post a Comment